Comparative Pharmacology
Head-to-head clinical analysis: BENICAR HCT versus VALSARTAN AND HYDROCHLOROTHIAZIDE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: BENICAR HCT versus VALSARTAN AND HYDROCHLOROTHIAZIDE.
BENICAR HCT vs VALSARTAN AND HYDROCHLOROTHIAZIDE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Combination of an angiotensin II receptor blocker (ARB) and a thiazide diuretic. Olmesartan blocks the vasoconstrictor and aldosterone-secreting effects of angiotensin II by selectively antagonizing the AT1 receptor. Hydrochlorothiazide inhibits the sodium-chloride symporter in the distal convoluted tubule, increasing excretion of sodium, chloride, and water, thereby reducing plasma volume.
Valsartan is an angiotensin II receptor blocker (ARB) that selectively inhibits the binding of angiotensin II to the AT1 receptor, thereby antagonizing angiotensin II-induced vasoconstriction, aldosterone secretion, and renal sodium reabsorption. Hydrochlorothiazide is a thiazide diuretic that inhibits the sodium-chloride symporter in the distal convoluted tubule, reducing sodium and water reabsorption.
One tablet orally once daily. Available strengths: 40 mg olmesartan / 12.5 mg hydrochlorothiazide, 40 mg olmesartan / 25 mg hydrochlorothiazide. Dose may be titrated after 2-4 weeks based on response.
Oral, one tablet once daily. Starting dose: 160/12.5 mg or 80/12.5 mg. Titrate to 160/25 mg or 320/12.5 mg-320/25 mg based on response. Max: 320/25 mg/day.
None Documented
None Documented
Olmesartan: Terminal elimination half-life is 10-15 hours, supporting once-daily dosing. Hydrochlorothiazide: Terminal half-life is 5.6-14.8 hours (mean ~10 hours), prolonged in renal impairment.
Valsartan: Terminal half-life ~6 hours; Hydrochlorothiazide: Terminal half-life ~6-15 hours (prolonged in renal impairment).
Olmesartan: Approximately 50-65% of absorbed dose excreted in urine (10-20% as unchanged drug, remainder as metabolites), 35-50% in feces via biliary excretion. Hydrochlorothiazide: ≥95% excreted renally as unchanged drug.
Valsartan: 83% eliminated via feces (biliary), 13% via urine; Hydrochlorothiazide: ≥95% eliminated unchanged via urine.
Category C
Category D/X
ARB + Thiazide Diuretic
ARB